Department of Organic and Medicinal Chemistry

3  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Ishida R, Zeng X, Kurebayashi N, Murayama T, Mori S, Kagechika H: Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical & pharmaceutical bulletin. 2024; 72 (4): 399-407. ( PubMed , DOI )

  1. Ishida R, Kurebayashi N, Iinuma H, Zeng X, Mori S, Kodama M, Murayama T, Masuno H, Takeda F, Kawahata M, Tanatani A, Miura A, Nishio H, Sakurai T, Kagechika H: A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European journal of medicinal chemistry. 2023.12; 262 115910. ( PubMed , DOI )

  1. Nao Namba, Tomomi Noguchi-Yachide, Yuichiro Matsumoto, Yuichi Hashimoto, Shinya Fujii: Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists. Bioorganic Medicinal Chemistry. 2022.05; 66 116792. ( PubMed , DOI )

To the head of this page.▲